Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 2.62 EUR 0.77%
Market Cap: 24.8m EUR

Relative Value

The Relative Value of one ALGEN stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.62 EUR, Genoway SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALGEN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
83
Median 3Y
1.7
Median 5Y
1.9
Industry
7.9
Forward
1
vs History
55
vs Industry
7
Median 3Y
22.6
Median 5Y
16.4
Industry
23.7
vs History
55
vs Industry
15
Median 3Y
4.7
Median 5Y
3.8
Industry
22
vs History
28
vs Industry
11
Median 3Y
8.9
Median 5Y
4.1
Industry
23.8
vs History
95
vs Industry
47
Median 3Y
2
Median 5Y
2.1
Industry
3.3
vs History
95
vs Industry
72
Median 3Y
1.8
Median 5Y
2.1
Industry
8.3
Forward
1
vs History
95
vs Industry
74
Median 3Y
1.9
Median 5Y
2.2
Industry
10.1
vs History
95
vs Industry
13
Median 3Y
5.8
Median 5Y
9.5
Industry
6.4
Forward
7.2
vs History
55
vs Industry
8
Median 3Y
19
Median 5Y
16.1
Industry
7
Forward
36.2
vs History
55
vs Industry
15
Median 3Y
4.6
Median 5Y
3.7
Industry
8.3
vs History
55
vs Industry
11
Median 3Y
7
Median 5Y
5.7
Industry
6.5
vs History
88
vs Industry
54
Median 3Y
1.4
Median 5Y
1.4
Industry
5.7

Multiples Across Competitors

ALGEN Competitors Multiples
Genoway SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Genoway SA
PAR:ALGEN
23.2m EUR 1 12.4 3.7 12.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
395.3B USD 6.6 168.4 16.3 23.2
US
Amgen Inc
NASDAQ:AMGN
175.8B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
147.5B USD 5.1 18.2 12.2 12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.6B USD 9.9 31.4 23.1 24.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.6B USD 5.5 17.2 16.3 18.5
AU
CSL Ltd
ASX:CSL
84B AUD 3.6 18.5 12.5 15.6
NL
argenx SE
XBRU:ARGX
45.1B EUR 14.7 34.6 59.6 61.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.6B USD 16.1 1 183.4 155.3 188.4
P/S Multiple
Revenue Growth P/S to Growth
FR
Genoway SA
PAR:ALGEN
Average P/S: 3 070 216.6
1
14%
0.1
FR
Pharnext SCA
OTC:PNEXF
33 770 229.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 086.1
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
14.7
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.1
46%
0.3
P/E Multiple
Earnings Growth PEG
FR
Genoway SA
PAR:ALGEN
Average P/E: 167.7
12.4
-19%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.4
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.2
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
9%
1.9
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
NL
argenx SE
XBRU:ARGX
34.6
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 183.4
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Genoway SA
PAR:ALGEN
Average EV/EBITDA: 35.2
3.7
-7%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
NL
argenx SE
XBRU:ARGX
59.6
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
155.3
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Genoway SA
PAR:ALGEN
Average EV/EBIT: 41.5
12.3
-7%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
13%
1.4
AU
CSL Ltd
ASX:CSL
15.6
11%
1.4
NL
argenx SE
XBRU:ARGX
61.3
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
188.4
N/A N/A